Oragenics
OGEN
10 hedge funds and large institutions have $174K invested in Oragenics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.01% less ownership
Funds ownership: 0.1% → 0.09% (-0.01%)
10% less capital invested
Capital invested by funds: $192K → $174K (-$18.9K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$93 |
| 2 |
Wells Fargo
San Francisco,
California
|
+$93 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$12.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.59K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$159 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $73.3K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $42K | -$12.6K | -136 | -24% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $41.2K | – | – | – |
|
4
Fidelity Investments
Boston,
Massachusetts
| $8.59K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $6.5K | +$93 | +1 | +2% |
|
|
6
UBS Group
Zurich,
Switzerland
| $1.32K | -$6.59K | -71 | -85% |
|
7
Bank of America
Charlotte,
North Carolina
| $374 | – | – | – |
|
8
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $116 | – | – | – |
|
|
WWM
9
Wolff Wiese Magana
Carslbad,
California
| $57 | – | – | – |
|
|
10
Wells Fargo
San Francisco,
California
| $50 | +$93 | +1 | New |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $19 | – | – | – |
|
|
CAM
12
Chesapeake Asset Management
New York
| $9 | – | – | – |
|
|
IA
13
IFP Advisors
Tampa,
Florida
| – | -$159 | -3 | Closed |
|
OGEN Hedge Fund Activity: Q2 2023 in Review
10 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q2 2023, worth a combined $174K — down 9.8% from $192K a quarter earlier.
Fund positioning in OGEN was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $93. The largest seller was Renaissance Technologies, cutting an estimated $12.6K.
- 10 institutional investors held Oragenics (OGEN) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $174K of Oragenics stock for Q2 2023, down 9.8% quarter-over-quarter.
- 1 fund opened new Oragenics positions in Q2 2023 and 1 closed out, a net change of 0 holders.
- The largest Oragenics buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $93 added.
- The largest Oragenics seller in Q2 2023 was Renaissance Technologies, an estimated $12.6K sold.
Based on aggregated 13F filings for Q2 2023.